- Young Female Smokers at Especially High Heart Risk
- Med Students’ Smartphones Loaded With Staph, Other Germs
- The Right Gut Bacteria May Give Athletes an Edge
- Coffee Might Be Your Go-to Brew for Weight Loss
- Nonchromosomal Birth Defects May Up Childhood Cancer Risk
- Anxiety With Type 2 Diabetes Tied to High-Cost Health Care Use
- Oral Steroids Increase Infection Risk in Inflammatory Disease
Karima Oualla, MD. Dr. Karima Oualla discusses recent advances on the use of checkpoint inhibitors in the treatment of triple negative breast cancer (TNBC). Dr. Oualla is an International expert in breast cancer and is the primary author of the manuscript entitled "Novel therapeutic strategies in the treatment of triple-negative… Robert L. Coleman, MD. Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of… Ted Lain, MD. Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Alzheimer’s disease (AD) is the most common cause of dementia in Western countries.
As I understand, this is a great step of development that we can use to save many people from horrible diseases. and i also hope Dr.Lain and your partners…
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.